## Introduction

## Overview
In September 2024, the epidemiological landscape of China's mainland was marked by a significant burden of various infectious diseases, manifesting in a considerable number of reported cases and deaths. Within the reported period, infectious respiratory diseases displayed a heavy impact, with Influenza and Tuberculosis accounting for the highest number of cases. The robust notifiable disease reporting system of China's mainland captured 1,199,771 cases of Influenza, resulting in 16 deaths, and reported 71,631 cases of Tuberculosis with a notably higher mortality at 230 deaths. It is noteworthy how the vigilant surveillance system enables the detection and recording of such extensive data, demonstrating the country’s commitment to public health monitoring and intervention.

Regarding mortality, Tuberculosis presented as the most lethal condition, with the recorded deaths underscoring its significant clinical impact despite advances in modern therapy and vaccination. The Hepatitis group of diseases also constituted a major public health concern, reporting over 126,743 cases and contributing to 54 fatalities. The mortality data reflect a critical need to bolster prevention, access to treatment, and strategic control interventions for these diseases, emphasizing the gravity of the continued epidemiological challenge they pose.

## Concerns
The high incidence of Hand, Foot, and Mouth Disease (HFMD) poses considerable concern, with 63,866 cases reported but resulting in only one death. This highlights the disease's vast potential for spread among the population, particularly affecting children, albeit with a low mortality rate. However, continuous monitoring is required to prevent outbreaks and manage complications that may arise. A significant increase in cases and public concern was noted for Hepatitis B, accumulating 102,151 cases. Although accounting for only 43 fatalities, the prevalence of Hepatitis B underscores the need for enhanced vaccination efforts and public awareness campaigns, especially considering the risk of chronic liver disease and hepatocellular carcinoma associated with the infection.

In the category of emerging infectious diseases, the high number of cases of infectious diarrhea (excluding cholera, dysentery, typhoid fever, and paratyphoid fever) at 122,103 is striking. With just one death reported, this might point towards mild illnesses and effective treatment strategies. However, such a high incidence requires sustained public health efforts in hygiene promotion, access to clean water, and sanitation to stem transmissions. Despite no fatalities reported, the introduction of Monkeypox into the Class B infectious diseases since September 2023 illustrates China’s evolving and adaptive disease surveillance in response to global infectious disease trends.

## Recommendations
To mitigate the spread and impact of infectious diseases, several recommendations emerge from this analysis. For Influenza, enhancing seasonal vaccination coverage is imperative, especially among the high-risk groups such as the elderly, young children, and patients with chronic diseases. Public health campaigns should also focus on proper hand hygiene practices and the importance of seeking medical attention when experiencing severe symptoms.

Given the substantial impact of Tuberculosis, there is an urgent need to ramp up the active screening in at-risk populations, improve ventilation in crowded living conditions, and ensure adherence to antitubercular treatment regimes. This should be complemented by investing in patient education programs regarding the importance of completing the entire course of treatment to prevent drug resistance.

Finally, for Hepatitis B, a nation-wide reinforcement of vaccination programs is crucial, especially targeting neonatal vaccination. This strategy should be backed by education drives aimed at reducing stigmatization and promoting safe injection practices and screening to identify and treat chronic infections early. Additionally, robust monitoring systems need to be maintained for emerging infectious diseases like Monkeypox, with preparedness plans put in place that include stockpiling vaccines and antivirals, and establishing clear protocols for contact tracing and isolation in the event of an outbreak.

Public adherence to these recommendations, combined with strong government-led initiatives in health education, preventive strategies, and early treatment, can significantly curb the prevalence and impact of infectious diseases across China's mainland.

## Latest Update

Version: 2024 September

| Diseases                                                                     | Cases   | Comparison with 2024 August   | Comparison with 2023 September   | Deaths   | Comparison with 2024 August   | Comparison with 2023 September   |
|:-----------------------------------------------------------------------------|:--------|:------------------------------|:---------------------------------|:---------|:------------------------------|:---------------------------------|
| [Cholera](./Cholera)                                                         | 1       | -3 (-75.00%)                  | -8 (-88.89%)                     | 0        | 0 (/)                         | 0 (/)                            |
| [SARS-CoV](./SARS-CoV)                                                       | 0       | 0 (/)                         | 0 (/)                            | 0        | 0 (/)                         | 0 (/)                            |
| [Acquired immune deficiency syndrome](./Acquired-immune-deficiency-syndrome) | 4,450   | -35 (-0.78%)                  | -671 (-13.10%)                   | 1,720    | 108 (6.70%)                   | 27 (1.59%)                       |
| [Hepatitis](./Hepatitis)                                                     | 146,669 | -17,079 (-10.43%)             | -1,089 (-0.74%)                  | 332      | -106 (-24.20%)                | 155 (87.57%)                     |
| [Hepatitis A](./Hepatitis-A)                                                 | 1,084   | -52 (-4.58%)                  | 46 (4.43%)                       | 0        | 0 (/)                         | 0 (/)                            |
| [Hepatitis B](./Hepatitis-B)                                                 | 125,765 | -14,280 (-10.20%)             | 2,270 (1.84%)                    | 29       | -13 (-30.95%)                 | 9 (45.00%)                       |
| [Hepatitis C](./Hepatitis-C)                                                 | 16,896  | -2,528 (-13.01%)              | -3,126 (-15.61%)                 | 303      | -92 (-23.29%)                 | 146 (92.99%)                     |
| [Other hepatitis](./Other-hepatitis)                                         | 471     | -51 (-9.77%)                  | -167 (-26.18%)                   | 0        | 0 (/)                         | 0 (/)                            |
| [Poliomyelitis](./Poliomyelitis)                                             | 0       | 0 (/)                         | 0 (/)                            | 0        | 0 (/)                         | 0 (/)                            |
| [Human infection with H5N1 virus](./Human-infection-with-H5N1-virus)         | 0       | 0 (/)                         | 0 (/)                            | 0        | 0 (/)                         | 0 (/)                            |
| [Measles](./Measles)                                                         | 118     | 7 (6.31%)                     | 40 (51.28%)                      | 0        | 0 (/)                         | 0 (/)                            |
| [Epidemic hemorrhagic fever](./Epidemic-hemorrhagic-fever)                   | 192     | -10 (-4.95%)                  | -6 (-3.03%)                      | 1        | 1 (/)                         | 0 (0.00%)                        |
| [Rabies](./Rabies)                                                           | 17      | -1 (-5.56%)                   | 9 (112.50%)                      | 12       | -7 (-36.84%)                  | 5 (71.43%)                       |
| [Japanese encephalitis](./Japanese-encephalitis)                             | 71      | 55 (343.75%)                  | 9 (14.52%)                       | 0        | 0 (/)                         | -1 (-100.00%)                    |
| [Dengue](./Dengue)                                                           | 4,845   | 3,044 (169.02%)               | -1,649 (-25.39%)                 | 0        | 0 (/)                         | -1 (-100.00%)                    |
| [Anthrax](./Anthrax)                                                         | 90      | -1 (-1.10%)                   | 29 (47.54%)                      | 1        | 0 (0.00%)                     | 0 (0.00%)                        |
| [Dysentery](./Dysentery)                                                     | 3,564   | -810 (-18.52%)                | -94 (-2.57%)                     | 0        | 0 (/)                         | 0 (/)                            |
| [Tuberculosis](./Tuberculosis)                                               | 55,609  | -2,335 (-4.03%)               | -6,250 (-10.10%)                 | 247      | -42 (-14.53%)                 | -77 (-23.77%)                    |
| [Typhoid fever and paratyphoid fever](./Typhoid-fever-and-paratyphoid-fever) | 612     | 62 (11.27%)                   | 16 (2.68%)                       | 0        | 0 (/)                         | 0 (/)                            |
| [Meningococcal meningitis](./Meningococcal-meningitis)                       | 5       | -6 (-54.55%)                  | 0 (0.00%)                        | 0        | 0 (/)                         | 0 (/)                            |
| [Pertussis](./Pertussis)                                                     | 17,316  | -25,900 (-59.93%)             | 12,799 (283.35%)                 | 2        | 1 (100.00%)                   | 2 (/)                            |
| [Diphtheria](./Diphtheria)                                                   | 0       | 0 (/)                         | 0 (/)                            | 0        | 0 (/)                         | 0 (/)                            |
| [Neonatal tetanus](./Neonatal-tetanus)                                       | 2       | 0 (0.00%)                     | 1 (100.00%)                      | 0        | 0 (/)                         | 0 (/)                            |
| [Scarlet fever](./Scarlet-fever)                                             | 2,179   | 151 (7.45%)                   | 633 (40.94%)                     | 0        | 0 (/)                         | 0 (/)                            |
| [Brucellosis](./Brucellosis)                                                 | 4,612   | -1,952 (-29.74%)              | -1,375 (-22.97%)                 | 1        | 1 (/)                         | -1 (-50.00%)                     |
| [Gonorrhea](./Gonorrhea)                                                     | 8,923   | -454 (-4.84%)                 | -1,224 (-12.06%)                 | 0        | 0 (/)                         | 0 (/)                            |
| [Syphilis](./Syphilis)                                                       | 54,136  | -4,581 (-7.80%)               | -1,631 (-2.92%)                  | 3        | 0 (0.00%)                     | -2 (-40.00%)                     |
| [Leptospirosis](./Leptospirosis)                                             | 128     | 37 (40.66%)                   | 57 (80.28%)                      | 0        | 0 (/)                         | 0 (/)                            |
| [Schistosomiasis](./Schistosomiasis)                                         | 0       | -3 (-100.00%)                 | -3 (-100.00%)                    | 0        | 0 (/)                         | 0 (/)                            |
| [Malaria](./Malaria)                                                         | 242     | -37 (-13.26%)                 | 49 (25.39%)                      | 0        | -1 (-100.00%)                 | -1 (-100.00%)                    |
| [Influenza](./Influenza)                                                     | 117,403 | -52,239 (-30.79%)             | -51,560 (-30.52%)                | 0        | 0 (/)                         | 0 (/)                            |
| [Mumps](./Mumps)                                                             | 9,657   | 2,965 (44.31%)                | -1,210 (-11.13%)                 | 0        | 0 (/)                         | 0 (/)                            |
| [Rubella](./Rubella)                                                         | 39      | -31 (-44.29%)                 | -33 (-45.83%)                    | 0        | 0 (/)                         | 0 (/)                            |
| [Acute hemorrhagic conjunctivitis](./Acute-hemorrhagic-conjunctivitis)       | 2,156   | -23 (-1.06%)                  | -123,108 (-98.28%)               | 0        | 0 (/)                         | 0 (/)                            |
| [Leprosy](./Leprosy)                                                         | 10      | -18 (-64.29%)                 | -13 (-56.52%)                    | 0        | 0 (/)                         | 0 (/)                            |
| [Typhus](./Typhus)                                                           | 188     | -19 (-9.18%)                  | -39 (-17.18%)                    | 0        | 0 (/)                         | 0 (/)                            |
| [Kala azar](./Kala-azar)                                                     | 33      | -1 (-2.94%)                   | 7 (26.92%)                       | 0        | 0 (/)                         | 0 (/)                            |
| [Echinococcosis](./Echinococcosis)                                           | 407     | 72 (21.49%)                   | 40 (10.90%)                      | 2        | 2 (/)                         | 2 (/)                            |
| [Filariasis](./Filariasis)                                                   | 0       | 0 (/)                         | 0 (/)                            | 0        | 0 (/)                         | 0 (/)                            |
| [Infectious diarrhea](./Infectious-diarrhea)                                 | 121,176 | -23,418 (-16.20%)             | 18,617 (18.15%)                  | 0        | -1 (-100.00%)                 | 0 (/)                            |
| [Hand foot and mouth disease](./Hand-foot-and-mouth-disease)                 | 35,054  | -7,169 (-16.98%)              | -131,926 (-79.01%)               | 0        | 0 (/)                         | 0 (/)                            |
| [Plague](./Plague)                                                           | 0       | -2 (-100.00%)                 | 0 (/)                            | 0        | -1 (-100.00%)                 | 0 (/)                            |
| [Hepatitis D](./Hepatitis-D)                                                 | 7       | -17 (-70.83%)                 | -8 (-53.33%)                     | 0        | 0 (/)                         | 0 (/)                            |
| [Hepatitis E](./Hepatitis-E)                                                 | 2,446   | -151 (-5.81%)                 | -104 (-4.08%)                    | 0        | -1 (-100.00%)                 | 0 (/)                            |
| [Human infection with H7N9 virus](./Human-infection-with-H7N9-virus)         | 0       | 0 (/)                         | 0 (/)                            | 0        | 0 (/)                         | 0 (/)                            |
| [Monkey pox](./Monkey-pox)                                                   | 46      | -2 (-4.17%)                   | -34 (-42.50%)                    | 0        | 0 (/)                         | 0 (/)                            |
| [Total](./Total)                                                             | 589,950 | -129,736 (-18.03%)            | -289,617 (-32.93%)               | 2,321    | -45 (-1.90%)                  | 108 (4.88%)                      |

## Source Data

<a href=https://github.com/xmusphlkg/globalID/tree/main/Data/AllData/CN><i class="fab fa-github"></i> Github</a>